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Summary
This systematic review examined the impact of exercise intervention programs on
selected cardiometabolic health indicators in adults with overweight or obesity. Three
electronic databases were explored for randomized controlled trials (RCTs) that
included adults with overweight or obesity and provided exercise-training
interventions. Effects on blood pressure, insulin resistance (homeostasis model of
insulin resistance, HOMA-IR), and magnetic resonance measures of intrahepatic fat in
exercise versus control groups were analyzed using random effects meta-analyses.
Fifty-four articles matched inclusion criteria. Exercise training reduced systolic and
diastolic blood pressure (mean difference, MD = 2.95 mmHg [95% CI 4.22,
1.68], p < 0.00001, I2 = 63% and MD = 1.93 mmHg [95% CI 2.73, 1.13],
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p < 0.00001, I2 = 54%, 60 and 58 study arms, respectively). Systolic and diastolic
blood pressure decreased also when considering only subjects with hypertension.
Exercise training significantly decreased HOMA-IR (standardized mean difference,
SMD = 0.34 [0.49, 0.18], p < 0.0001, I2 = 48%, 37 study arms), with higher
effect size in subgroup of patients with type 2 diabetes (SMD = 0.50 [95%
CI: 0.83, 0.17], p = 0.003, I2 = 39%). Intrahepatic fat decreased significantly after
exercise interventions (SMD = 0.59 [95% CI: 0.78, 0.41], p < 0.00001, I2 = 0%),
with a larger effect size after high-intensity interval training. In conclusion, exercise
training is effective in improving cardiometabolic health in adults with overweight or
obesity also when living with comorbitidies.
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1 | INTRODUCTION
Obesity is a global and growing multifactorial disease as well as a pub-
lic health issue.1 The pandemic expansion of obesity is accompanied
by the concomitant growth of many related comorbidities, themselves
determinants of increased cardiovascular risk.2 Indeed, increased
blood glucose, high blood pressure, altered lipid profile, and increased
intrahepatic fat are all cardiometabolic risk markers closely related to
obesity, with insulin resistance as a common pathophysiological
pathway.3 All international guidelines recommend to prescribe
physical exercise for the management of type 2 diabetes,4 arterial
hypertension,5 and obesity-related comorbidities such as nonalcoholic
fatty liver disease (NAFLD).6 However, the effect of exercise training
on these aspects of cardiometabolic health have not been specifically
addressed in subjects with overweight or obesity. In 2006, a Cochrane
review based on a very limited number of randomized controlled trials
(RCTs) available showed that groups of adults with overweight or
obesity participating in physical exercise intervention programs
experienced advantages for cardiometabolic health (i.e., blood pres-
sure lowering and improved lipid profile), particularly if involved in
higher-intensity exercise training.7 In 2013, Pattyn et al.,8 focusing on
subjects with metabolic syndrome, displayed the efficacy of aerobic
training in improving cardiovascular risk factors. In 2012, Cornelissen
et al.9 described the significant effect of resistance training in reducing
systolic and diastolic blood pressure, but this meta-analysis did not
address individuals with overweight or obesity. Moreover, previous
systematic reviews and meta-analysis outlined significant effect of
regular exercise in improving insulin sensitivity in patients with type
2 diabetes, but limited data are available in patients with overweight
and obesity with or without type 2 diabetes.10,11
High-intensity interval training (HIIT) is currently receiving
increasing attention regarding its metabolic and cardiovascular effects.
Recently, Batacan et al.12 highlighted the beneficial effect of HIIT on
cardiometabolic health in subjects with overweight or obesity. On the
other hand, also high intensity continuous training showed powerful
effect in reducing intrahepatic fat, a main marker of metabolic
dysfunction in people with obesity.13 NAFLD is currently recognized
as a major health concern, considering that it can give rise to serious
forms of liver disease such as cirrhosis and hepatic carcinoma.14 Prior
reviews showed that exercise training alone is effective in reducing
different measures of intrahepatic fat in patients with NAFLD,13,15,16
particularly for higher energy expenditure programmes.17
In summary, a specific focus on overweight or obesity is lacking in
most previous reviews and meta-analyses. Therefore, given the growing
number of individuals affected by obesity-related comorbidities18–21
and the central role of physical exercise in their management,22 it
seemed suitable to perform an update and synthesis about the effect
of exercise training programs on cardiometabolic health parameters in
adults with overweight or obesity. The main objective of this work is to
evaluate through systematic review and meta-analysis the effect of
exercise training on blood pressure values, insulin resistance, and
magnetic resonance (MR) measures of intrahepatic fat in patients with
overweight or obesity with or without obesity-related comorbidities.
2 | METHODS
This systematic review follows the Preferred Reporting Items for
Systematic Reviews and Meta-Analysis (PRISMA) guidelines and is
registered in the PROSPERO database (registration number
CRD42019157823).
2.1 | Search strategy
Three electronic databases (PubMed, Web of Science, and Cochrane
Library) were searched for original articles published up to April 2020
using the strategy “obesity AND physical activity AND age AND
comorbidities.” Previous systematic reviews were screened to identify
relevant subject headings and keywords to include within each
subject category. The specific keywords used for the search are listed
in Table S1. Limits were set to include RCTs, only with adults, and that
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were published in English. Reference lists from the resulting articles
were also screened to identify additional articles.
2.2 | Study selection, inclusion, and exclusion
RCTs were included if they involved adults (≥18 years including older
adults) with overweight (body mass index [BMI] ≥ 25 kg/m2) or obe-
sity (BMI ≥ 30 kg/m2) participating in physical activity interventions,
that is, exercise training programs. Original articles focusing on the
primary prevention of weight gain/obesity were not included. Pres-
ence of obesity comorbidities was not an exclusion criterion, provided
that the article focused on subjects with obesity. Specifically, subjects
with the following comorbidities were not excluded: type 2 diabetes,
hypertension, dyslipidaemia, metabolic syndrome, NAFLD, and non-
alcoholic steatohepatitis (NASH). No minimum intervention length
criterion was applied. Exercise training programs included sessions
with one or more types of exercise (aerobic and/or resistance and/or
HIIT). Exercise sessions could have been fully supervised, partially
supervised or nonsupervised. Physical activity programs in combina-
tion with other interventions (e.g., diet, dietary supplements, or drugs)
with appropriate controls were included. Comparators included no
intervention or usual care (i.e., intervention that any patient would
have received in the framework of obesity management).
Abstracts and full texts were independently assessed for eligibility
by two authors (FB and AE) with uncertainty regarding eligibility
discussed among authors.
2.3 | Data extraction and synthesis
Data were extracted by two authors (FB and AE) using standardized
forms. Characteristics of each included original article were recorded:
reference, study design, participants included in intervention and
control groups, population characteristics (age, BMI, % female, and
comorbidities for intervention and control groups), description of
intervention (program duration, number of sessions/week, type
of training/modality, and supervision/delivery), and comparison, out-
comes, and duration of follow-up.
The findings pertaining to systolic blood pressure, diastolic blood
pressure, insulin resistance, and intrahepatic fat (measured only by
MR) of each included original article are reported. In addition, the
study authors' conclusions were extracted, and an overview of
the quality of the original studies and current authors' assessment of
conclusions is provided for each included article.
Effects on systolic and diastolic blood pressure, Homeostasis
Model Assessment Insulin Resistance Index (HOMA-IR), and
intrahepatic fat were examined using random effects meta-analyses
(Review Manager Version 5.3). Analyses are presented as mean
difference (MD) for systolic and diastolic blood pressure and as
standardized mean difference (SMD) for HOMA-IR and intrahepatic
fat. Sensitivity analysis by using one-study-removed procedure was
also conducted. Effect sizes were considered large, medium, small, and
negligible when SMD was >0.8, between 0.5 and 0.8, between 0.2
and 0.5, and below 0.2, respectively. Heterogeneity was calculated
using the I2 test. Heterogeneity was considered low, moderate, and
high when I2 was <50%, between 50% and 75%, and ≥75%, respec-
tively.23 Publication bias was assessed with visual inspection of the
funnel plot. Limit for statistical significance was fixed at a p value of
0.05. Absolute change (pre- to postintervention values) in intervention
and control groups was indicated as mean and standard deviation (SD).
For missing data, authors were contacted. Alternatively, conversion of
confidence intervals in SD or calculation of SD of absolute
change (when studies provided the exact p value for intragroup
or intergroup analyses) was performed by formulas and
transformation methods of the Cochrane handbook.24 When these
values were not reported, we calculated the MD as the difference in
mean pre- and postintervention and its SD using the formula:
SD = square root ([SDpretreatment]
2 + [SDposttreatment]
2) – [2r 
SDpretreatment  SDposttreatment]). Because the pretest–posttest correla-
tion coefficients (r) were not reported in the studies, a conservative
r value of 0.5 was assumed throughout. Data from figures were
extracted using an online tool (WebPlotDigitizer; https://automeris.
io/WebPlotDigitizer/). If a study included more than two experimental
groups, which were compared with one control group, the number of
subjects in the control group was divided by the number of included
intervention arms.
2.4 | Quality assessment
Study quality was assessed with a standardized tool including
14 criteria, as previously described.25 Study quality was defined as
good, fair, and poor when 0, 1, or ≥2 criteria considered as “fatal flaws”
were not fulfilled.25 Three assessment items represented fatal flaws if
answered “No/Not reported/Can't determine”: (i) randomization (#1),
(ii) dropout rate <20% (#7), and (iii) intent-to-treat analysis (#14).
Quality assessment was conducted independently by two reviewers
(FB ad AE) using this standardized tool. Any disagreement between
the reviewers was resolved through discussion.
3 | RESULTS
The systematic review flow diagram is presented in Figure 1. The
comprehensive (databases and reference lists) search yielded 6768
articles; 1418 were removed because they were duplicates. Of the
remaining 5350, 5108 were eliminated based on titles and abstracts
alone. The full text was retrieved from 242 articles, and 54 satisfied
the inclusion criteria.
3.1 | Study characteristics
Characteristics and findings of the included original studies are pres-
ented in Tables S3–S4. RCTs were published between 2006 and April
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2020. Fifty-four RCTs were included. The median (range) total sample
size of the included studies was 38 (10–404) subjects. The median
(range) age was 52 (22–70) years. Fifty-three studies reported BMI at
baseline, with the median (range) being 31.9 (26.3–43.7) kg/m2. In the
single study26 not reporting BMI values, the presence of obesity
(BMI ≥ 30 kg/m2) was an inclusion criteria. Males and females were
present in 34 studies18,21,26–57 in which the median (range) percent-
age of females was 59.0 (15.9–92.1)%. Eight studies included only
male,58–65 and 12 studies included only female adults.66–77 Five stud-
ies included subjects with several comorbidities including arterial
hypertension, type 2 diabetes, and metabolic syndrome.27,43,46,47,53
Six studies included patients with hypertension and metabolic syn-
drome.26,36,44,54,57,68 Four studies were performed on subjects
affected by hypertension and NAFLD,41,51,55,78 three studies included
subjects affected by NAFLD and type 2 diabetes,28,29,50 and two
included also patients with dyslipidaemia.18,52 Two studies enrolled
patients with only type 2 diabetes,49,58 12 studies with only
hypertension,30,31,33,39,42,48,62–64,66,71,75 one with NAFLD,45 and one
with NASH.32 Interventions are described in detail in Table S3. Dura-
tion of exercise training ranged from 4 to 48 weeks, with a median
duration of 12 weeks and a median of 3 (range 2–7) sessions/week.
Aerobic training was performed in 36 studies, resistance training in
12 studies, a combination of aerobic and resistance training in eight
studies, and HIIT in 11 studies. Exercise duration was prescribed in
minutes or as energy expenditure (kcal), and the exercise intensity
defined as percentage of maximal aerobic capacity (VO2max) or
heart rate (HRmax or HRReserve). The mean (range) exercise pre-
scription was 45 (17–90) min per session or 1698 (668–2430) kcal/
week at 60 (45–85)% VO2max, 70 (50–85)% HRmax, or
60 (45–80)% HRReserve for aerobic training. Resistance training
was prescribed with a median (range) of 3 (2–4) sets of 10 (8–15)
repetitions for 8 (4–12) exercises at 70 (60–85)% of 1 RM. HIIT
was prescribed as a median (range) of 5 (3–11) bouts of
128 (30–480) s at 90 (85–95)% VO2max or 90 (80–100)% HRmax
with a median (range) recovery duration of 120 (45–180) s at
50 (20–70)% VO2max or 70 (70–70)% HRmax. Four studies
evaluated exercise intensity as rate of perceived exertion (RPE)
measured with Borg scale with a median value of 14 (13–18). One
study prescribed exercise training at individualized VO2,
corresponding to maximal fat oxidation (34.5%, range 24.4–46.8%
VO2max). Exercise sessions were fully supervised in 28 studies,
partially supervised in 14 studies, and not supervised in five
studies. Information about supervision was not reported in
seven studies. Supervision was conducted by physical therapists,
physicians, fitness instructors, exercise physiologists or specialists,
or kinesiologists. Control groups were characterized by no exercise
prescription, sham exercise (i.e., stretching), usual care, or dietary
prescription, if the intervention group received a diet prescription
plus exercise. One study compared exercise and rosiglitazone
versus rosiglitazone alone considered as control group. Reported
outcomes included systolic blood pressure (36 studies), diastolic
blood pressure (35 studies), HOMA-IR (30 studies), and intrahepatic
fat (13 studies). Except for two RCTs that assessed outcome after
the conclusion of the exercise intervention program 6-54 and
8-month follow-ups,30 all RCTs reported measures recorded
immediately after the intervention period. When studies reported
more than one follow-up measure, those assessed immediately after
the conclusion of the intervention period were chosen.
F IGURE 1 Preferred
Reporting Items for Systematic
Reviews and Meta-Analysis
(PRISMA) flow diagram
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3.2 | Study findings
Findings of the included studies are listed in Table S4.
3.2.1 | Blood pressure
Included outcomes were systolic and diastolic blood
pressure assessed as office measures. Only two RCTs48,63 used 24-h
blood pressure monitoring (ABPM), and the mean of daytime
measures was included in meta-analyses. Nine studies included only
subjects with prehypertension or hypertension, six studies included
only subjects with normal blood pressure, and 16 studies included
mixed populations, that is, subjects with or without hypertension.
3.2.2 | Systolic blood pressure
To assess the overall effect of exercise on systolic blood pressure, all
studies were included in the meta-analysis, whatever the blood pressure
status (60 study arms, 1334 subjects in the experimental groups, and
942 subjects in the control groups). As shown in Figure S1, exercise
training programs were effective in reducing systolic blood pressure
(MD: 2.95 mmHg [95% CI: 4.22, 1.68], p < 0.00001, I2 = 63%).
When including only studies with hypertensive subjects (17 study arms),
blood pressure was reduced on average by 3.39 mmHg (95% CI
5.31, 1.46), p = 0.0006, I2 = 58% (Figure 2). When including only
studies with normotensive subjects (eight study arms), the effect was
not significant (MD: 2.03 mmHg [95% CI: 5.32, 1.26], p = 0.23,
I2 = 31%). Funnel plots all looked symmetric (Figure S5a).
F IGURE 2 Forest plot of the effect of exercise training versus control on systolic blood pressure in adults with overweight or obesity,
grouped by presence/absence of arterial hypertension. Presents mean difference between subjects participating in exercise training versus
control in change of systolic blood pressure. Subgroup “Normotensive patients” includes randomized controlled trials (RCTs) that excluded
patients with overweight or obesity and hypertension. Subgroup “Pre-hypertension or hypertension” includes RCTs that included only patients
with overweight or obesity and prehypertension or hypertension. Articles are presented in alphabetical order. Abdelaal 2014 (a): aerobic exercise;
Abdelaal 2014 (b): resistance exercise. Fenkci (a): aerobic training; Fenkci (b): resistance training. Figueroa 2015 (a): high ankle blood pressure;
Figueroa 2015 (b): low ankle blood pressure. Gorostegi-Anduaga 2018 (a): high volume-moderate intensity continuous training; Gorostegi-
Anduaga 2018 (b): high volume-high intensity interval training; Gorostegi-Anduaga 2018 (c): low volume-high intensity interval training. Meckling
(a): control diet + exercise versus control diet; Meckling (b): high protein diet + exercise versus high-protein diet. Mohr 2014 (a): moderate
intensity continuous training versus control. Mohr 2014 (b): high intensity interval training versus control. Schroeder 2018 (a): aerobic exercise;
Schroeder 2018 (b): resistance exercise; Schroeder 2018 (c): combined exercise. Swift 2012 (a): lower energy expenditure (8 kcal/kg/week); Swift
2012 (b): higher energy expenditure (12 kcal/kg/week)
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Sensitivity analyses were conducted according to study quality.
Out of the 36 studies included in the meta-analyses, 24 studies were
rated as fair or good quality and 12 as poor quality (Table S2). When
eliminating the poor-quality studies, the overall effect on systolic
blood pressure remained unchanged (MD: 3.04 mmHg [95% CI:
4.37, 1.71], p < 0.00001, I2 = 54%). Sensitivity analyses performed
by eliminating the two studies that used ABPM did not reveal sub-
stantial differences in the overall MD. One-study removing sensitivity
analyses did not change the overall result.
3.2.3 | Diastolic blood pressure
A total of 58 study arms (1310 subjects in the experimental groups
and 930 subjects in the control groups) were included to assess the
overall effect of exercise training programs on diastolic blood pressure
(whatever the initial blood pressure status). As shown in Figure S2,
exercise training programs were effective in reducing diastolic blood
pressure (MD: 1.93 mmHg [95% CI: 2.73, 1.13], p < 0.00001,
I2 = 54%). Blood pressure decreased significantly with exercise, both
when including only studies with hypertensive subjects (16 study
arms), (MD: 2.06 mmHg [95% CI: 3.42, 0.70], p = 0.003,
I2 = 76%), and only studies with normotensive subjects (eight study
arms) MD: 2.09 mmHg (95% CI: 3.45, 0.74), p = 0.002, I2 = 0%),
as reported in Figure 3. Funnel plots demonstrated a symmetric distri-
bution (Figure S5b).
Twenty-three studies were rated as fair or good quality and
12 as poor quality (Table S2). When eliminating the poor-quality
studies, the overall effect of exercise was comparable (MD:
1.98 mmHg [95% CI: 2.87, 1.09], p < 0.0001, I2 = 54%). Sensi-
tivity analyses performed by eliminating the two studies that used
ABPM did not reveal substantial differences in the overall MD. One
study removing sensitivity analyses did not change the overall
result.
F IGURE 3 Forest plot of the effect of exercise training versus control on diastolic blood pressure in adults with overweight or obesity,
grouped by presence/absence of arterial hypertension. Presents mean difference between subjects participating in exercise training versus
control in change of diastolic blood pressure. Articles are presented in alphabetical order. Subgroup “Normotensive patients” includes randomized
controlled trials (RCTs) that excluded patients with overweight or obesity and hypertension. Subgroup “Pre-hypertension or hypertension”
includes RCTs that included only patients with overweight or obesity and prehypertension or hypertension. Abdelaal 2014 (a): Aerobic exercise;
Abdelaal 2014 (b): resistance exercise. Fenkci (a): aerobic training; Fenkci (b): resistance training; Gorostegi-Anduaga 2018 (a): high volume-
moderate intensity continuous training; Gorostegi-Anduaga 2018 (b): high volume-high intensity interval training; Gorostegi-Anduaga 2018 (c):
low volume-high intensity interval training. Meckling (a): control diet + exercise versus control diet; Meckling (b): high protein diet + exercise
versus high protein diet. Mohr 2014 (a): moderate intensity continuous training versus control; Mohr 2014 (b): high intensity interval training
versus control. Schroeder 2018 (a): aerobic exercise; Schroeder 2018 (b): resistance exercise; Schroeder 2018 (c): combined exercise. Swift 2012
(a): higher energy expenditure (12 kcal/kg/week); Swift 2012 (b): lower energy expenditure (8 kcal/kg/week)
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3.2.4 | Insulin resistance
Out of the 30 RCTs that reported HOMA-IR, 18 studies included sub-
jects without type 2 diabetes, eight studies included subjects with
type 2 diabetes, one study assessed three arms of intervention based
on the glycaemic status, and three studies provided no information or
included mixed populations. A total of 37 study arms (740 subjects in
the experimental groups and 697 subjects in the control groups) were
included to assess the overall effect of exercise training programs on
insulin resistance (whatever the initial glycemic status). As shown in
Figure S3, exercise reduced HOMA-IR (SMD: 0.34 [95% CI: 0.49,
0.18], p < 0.0001, I2 = 48%). HOMA-IR decreased significantly
when we included only interventions performed in subjects with type
2 diabetes (SMD: 0.50 [95% CI: 0.83, 0.17], p = 0.003, I2 = 39%)
or only interventions performed in subjects without type 2 diabetes
(SMD:0.31 [95% CI:0.49,0.13], p = 0.0007, I2= 45%) (Figure 4).
Funnel plots demonstrated a symmetric distribution (Figure S5c).
Fifteen studies were rated as fair or good quality and 15 as poor
quality. Removing the poor-quality studies did not change the overall
effect of exercise (SMD: 0.38 [95% CI: 0.56, 0.20], p < 0.0001,
I2 = 34%). One study removing sensitivity analyses did not change
the overall result.
F IGURE 4 Forest plot of the effect of exercise training versus control on Homeostasis Model Assessment Insulin Resistance Index (HOMA-
IR) in adults with overweight or obesity, grouped by presence/absence type 2 diabetes. Presents mean difference between subjects participating
in exercise training versus control in change of HOMA-IR. Articles are presented in alphabetical order. Subgroup “No type 2 diabetes” includes
randomized controlled trials (RCTs) that excluded patients with overweight or obesity and type 2 diabetes. Subgroup “Type 2 diabetes” includes
RCTs that included only patients with overweight or obesity and type 2 diabetes. Articles are presented in alphabetical order. Bouchonville 2014
(a): exercise versus control. Bouchonville 2014 (b):diet + exercise versus diet; Fenkci (a): aerobic training; Fenkci (b): resistance training. Fritz 2012
(a): normal glucose tolerance; Fritz 2012 (b): impaired glucose tolerance; Fritz 2012 (c): type 2 diabetes. Kadoglou 2010 (a): exercise versus
control; Kadoglou 2010 (b): rosiglitazone + exercise versus rosiglitazone. Oh 2018 (a): diet + exercise versus diet; Oh 2018 (b): exercise versus
control; Winding 2014 (a): endurance training; Winding 2014 (b): high intensity interval training
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3.2.5 | Intrahepatic fat
Out of the 13 studies assessing the effect of exercise on MR mea-
sures of intrahepatic fat, nine studies included subjects with NAFLD,
one study included subjects with NASH, and three studies included
mixed populations (with and without NAFLD). A total of 17 study
arms (329 subjects in the experimental groups and 189 subjects in the
control groups) were included to assess the overall effect of exercise
training programs on intrahepatic fat (whatever the initial status of
participants and the type of exercise). Exercise reduced intrahepatic
fat (SMD: 0.59 [95% CI: 0.78, 0.41], p < 0.00001, I2 = 0%)
(Figure S4). The funnel plot was symmetric (Figure S5d). Meta-
analyses stratified according to the type of exercise training (Figure 5)
showed that HIIT, aerobic, and resistance alone or combined with aer-
obic training all decreased intrahepatic fat (SMD: 0.89 [95% CI:
1.36, 0.41], p = 0.0002, I2 = 0%; SMD: 0.56 [95% CI: 0.77,
0.35], p < 0.00001, I2 = 0%; and SMD: 0.40 [95% CI 1.06, 0.26],
p = 0.24, I2 = 0%, respectively).
Nine studies were rated as fair or good quality and four as poor
quality. Removing the poor-quality studies, the overall effect of
exercise did not change (SMD: 0.59 [95% CI: 0.80, 0.38],
p < 0.00001, I2 = 0%). One study removing sensitivity analyses did
not change the overall result.
3.3 | Study quality
Study quality was rated as good, fair, and poor in 11 (20%), 20 (37%),
and 23 (43%) studies, respectively (Table S2). Most RCTs did not per-
form intention to treat analysis (Criterion 14), blinding of participants
was generally not applicable (Criterion 4), and blinding of allocation
and of the people assessing outcomes (Criteria 3 and 5) was not
accomplished in more than half of the RCTs.
4 | DISCUSSION
This systematic review and meta-analysis provides a comprehensive
analysis on the effect of exercise training interventions on key aspects
of cardiometabolic health in adults with overweight or obesity. Our
F IGURE 5 Pooled analysis for the effect of exercise training versus control on intrahepatic fat in adults with overweight or obesity, grouped
by exercise modality. Presents mean difference between subjects participating in exercise training versus control in change of intrahepatic fat.
Articles are presented in alphabetical order. Keating 2015 (a): high intensity, low volume aerobic exercise; Keating 2015 (b): low intensity, high
volume aerobic exercise. Keating 2015 (c): low intensity, low volume aerobic exercise. Winn 2017 (a): high intensity interval training; Winn 2017
(b): moderate intensity continuous training; Zhang 2016 (a): moderate intensity training; Zhang (b): vigorous intensity training
8 of 15 BATTISTA ET AL.
results demonstrate that exercise training programs are effective in
improving cardiometabolic health in adults with overweight or
obesity, including patients living with obesity-related comorbidities.
4.1 | Blood pressure
An overall reduction in both systolic and diastolic blood pressure was
observed. The reduction of systolic blood pressure, whatever the
blood pressure status of participants, was about 2 mmHg. Similar
reductions in blood pressure have been previously reported after
exercise training, although the effect of exercise was not specifically
assessed in subjects with overweight or obesity.79 Interestingly, we
found that the decrease in blood pressure appeared to be larger in
subjects with hypertension compared with normotensive patients,
reaching on average 3 mmHg versus a nonsignificant effect. This is in
line with results of Cornelissen and Smart that reported a larger effect
of resistance exercise training on systolic blood pressure in subjects
with hypertension compared with those with prehypertension or
normal blood pressure.80 It should be noted, however, that even a
small decrease in systolic blood pressure of 2 mmHg is associated
with a 10% decrease in stroke mortality and 7% decrease in ischemic
heart disease and vascular mortality in middle-aged adults.81 There-
fore, the observed reduction in blood pressure resulting from exercise
training in subjects with overweight or obesity may bring substantial
health benefits in the long term. Despite a relatively large number of
studies included in our meta-analysis (N = 54), the heterogeneity of
participants, especially regarding their initial blood pressure status,
was important and prevented us from comparing different types of
exercise training. In studies enrolling only patients with hypertension,
a majority of study arms was based on aerobic training; this enabled
us to conclude that aerobic exercise is effective in reducing systolic
and diastolic blood pressure in subjects with overweight or obesity
and hypertension. A recent systematic review focusing on individuals
with hypertension confirmed the efficacy of aerobic exercise and
highlighted the potential role of HIIT in reducing blood pressure
values with a greater magnitude.82 Also, resistance training seems to
have similar effect in reducing blood pressure, with higher effect in
patients with hypertension.83–85 These findings cannot yet be
extended to hypertensive subjects with overweight or obesity
because of the currently limited available data.
A further source of heterogeneity came from the interventions
provided in addition to exercise training. One study, by Larson-Meyer
et al.,38 aimed to assess the effect of energy intake restriction versus
energy intake restriction plus aerobic exercise, whereas the research
of Kadoglu et al.34 was the only one combining exercise and drug
treatment and one of the two with a long duration of the intervention
(48 weeks). Nevertheless, the overall effect did not significantly
change by eliminating these studies from the meta-analysis. Although
previous data have shown that the effect of exercise is higher when it
is associated with weight loss,86 there are several exercise-induced
mechanisms that can explain blood pressure lowering, independently
from weight loss.87 Indeed, changes in body composition, particularly
when characterized by increased lean mass and decreased adipose
tissue, especially ectopic fat, are able to improve the endocrine, meta-
bolic, and inflammatory profile, with beneficial effects on blood pres-
sure control.35,88 In this connection, mice experiments demonstrated
that increasing muscle mass improves obesity-associated hyperten-
sion and that a plausible mechanism involves the relationship between
glucose metabolism and the vascular and renal function.89 Accord-
ingly, a previous meta-analysis focused on the effect of dynamic
resistance training in prehypertensive patients showed a significant
reduction in systolic and diastolic blood pressure values, with a
notable dose–response relationship.90 A link between myokines
(i.e., myostatin) and arterial stiffness has also been recently described
in healthy adolescents.91 Moreover, the improvement of endothelial
function, arterial structure, and stiffness due to vasodilation and the
reduction of vascular oxidative stress play also an important role in
reducing blood pressure in response to exercise training.92,93
4.2 | Insulin resistance
Exercise training programs were effective in reducing insulin resis-
tance in patients with overweight or obesity, with or without type
2 diabetes. Current results confirm findings of Thaane et al.10 who
found a significant effect on insulin sensitivity, examining the effect of
short term exercise training (<12 weeks) in subjects with overweight
or obesity and type 2 diabetes. In addition, authors stated that the
effect was poorly influenced by weight loss and was more pro-
nounced for vigorous exercise. The efficacy of exercise was demon-
strated also for dynamic measures of insulin sensitivity (i.e., clamp,
oral glucose tolerance test, and insulin tolerance test), in patients with
type 2 diabetes.11 It is known that physical exercise improves meta-
bolic flexibility also by increasing insulin-dependent glucose uptake,
particularly in individuals with type 2 diabetes.94 Furthermore, physi-
cal exercise can enhance glucose metabolism not only in muscle but
also in adipose and hepatic tissue,95 determining an overall improve-
ment of insulin sensitivity.96 Overall, it is still unknown what the best
exercise prescription would be (i.e., modality, volume, and intensity of
exercise) to improve insulin sensitivity in patients with obesity and
type 2 diabetes. Our systematic review found nine RCTs including
only patients with type 2 diabetes, and only one performed resistance
training, three performed HIIT, and five performed aerobic exercise.
However, our subanalysis suggests that aerobic exercise, also includ-
ing high intensity, reduces insulin resistance in patients with obesity
and type 2 diabetes. Previous studies indicated that high-intensity
exercise had a greater beneficial effect than moderate intensity exer-
cise on insulin resistance.97 Actually, high-intensity exercise seems to
have a more pronounced effect in recruiting glycolytic fibers,98 and in
decreasing visceral fat,99 counteracting insulin resistance. Also for this
outcome, heterogeneity was partly reduced by removing the study of
Kadoglu et al.34 without changes in the overall effect. In this system-
atic review, it was not possible to identify the role played by exercise
in improving insulin sensitivity, regardless of weight loss. Neverthe-
less, possible explanations for a higher insulin sensitivity can rely on
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the reduction in visceral adipose tissue and the virtuous hormonal cas-
cade leading to a multiorgan improvement of glucose metabolism.87
On the other hand, also a quantitative and qualitative improvement in
muscle mass induced by exercise training may explain the enhance-
ment in insulin sensitivity observed in subjects with obesity with or
without type 2 diabetes that followed exercise programs.11,100,101
From a clinical perspective, it is well-known that enhancement of
insulin sensitivity, rather than plasma glucose level, has a major role in
improving diabetes outcomes, while insulin resistance is a better pre-
dictor of future cardiovascular events in nondiabetic individuals.99
Furthermore, there is compelling evidence that insulin resistance by
itself is a cardiovascular risk factor in a variety of population groups,
including the general population and patients with diabetes.99
4.3 | Intrahepatic fat
Our results show the effective role of exercise training in reducing
MR measures of intrahepatic fat in groups of adults with overweight
or obesity. These findings are in line with previous reviews that
pointed in the same direction. Keating et al. in 2012 showed
that exercise training alone is effective in reducing intrahepatic fat in
patients with NAFLD.35 Similarly, in 2017, Katsagoni et al. showed
that exercise, alone or combined with dietary intervention, improves
serum hepatic enzymes and intrahepatic fat (moderate to large effect
size) in patients with NAFLD even in absence of weight loss.13 This
well-conducted systematic review included all types of intrahepatic
fat measures (MR, ultrasound, and liver biopsy). Our work is focused
on MR measures of intrahepatic fat, with 10 included studies using
MR spectroscopy and the others with MR imaging. MR is the noninva-
sive method that better correlates with liver biopsy, recognized as the
gold standard for the identification of liver steatosis. These MR tech-
niques showed great accuracy and high intraindividual reproducibil-
ity.102 Hence, restricting meta-analysis to studies that used these
methods for intrahepatic fat quantification strengthen the reliability
of our findings. In 2018, Smart et al. described the effect of exercise
alone on surrogate markers of liver function, in subjects with over-
weight/obesity or fatty liver disease. The authors described a signifi-
cant effect of exercise in reducing intrahepatic fat, particularly when
selecting RCTs based on energy expenditure (at least 10,000 kcal for
the total exercise program) and exercise without a diet intervention
(only three studies included). Our pooled analyses showed that HIIT
has the larger effect size in reducing intrahepatic fat, even though
other exercise modalities also exhibited a statistically significant
effect. Similar results were previously suggested by Katsagoni et al.,13
who showed that the effect on intrahepatic fat was larger for higher
intensity and volume of training. These results can be achieved inde-
pendently from weight loss.13 Several mechanisms can be responsible
for the effect of exercise on NAFLD.103 In fact, it is well-known that
physical exercise is effective in decreasing hepatic lipogenesis104 and
gluconeogenesis and in improving skeletal muscle glycogen synthesis,
resulting in lower plasma and liver triglycerides105 and higher insulin
sensitivity, also in patients with obesity.106 NAFLD shares common
pathophysiological pathways with sarcopenia, such as insulin resis-
tance and inflammation, and people that perform regular exercise
have a lower probability to develop NAFLD. Indeed, a preserved mus-
cle mass seems to be a key component for the exercise-induced ame-
lioration of fatty liver.107 Further experimental studies in rats report
the increase of mitochondrial oxidation of lipids and the prevention or
attenuation of the endoplasmic reticulum stress, a condition tightly
linked to reactive oxygen species generation, chronic low-grade
inflammation, and apoptosis in the setting of metabolic diseases.13
The efficacy of exercise in reducing intrahepatic fat levels has
important clinical implications. Indeed, liver fat content is considered a
sensitive “barometer” for metabolic health.108 Intrahepatic fat accu-
mulation leads to NAFLD, a condition recognized as the hepatic mani-
festation of the metabolic syndrome and metabolically related with
adipose tissue insulin resistance and diabetes pathophysiology.109
5 | LIMITATIONS AND PERSPECTIVES
Physical exercise and pharmacological treatments are both key com-
ponents for the management of obesity and its related comorbidities.
Their interactive effects might be explained by shared metabolic and
vascular mechanisms, with a potential synergistic or compensatory
effect on cardiometabolic health.110–112 However, future studies
should explore the actual relationship between antidiabetic and/or
anti-obesity agents and exercise, in order to identify the best combi-
nation of pharmacological and nonpharmacological individualized
treatment for each patient. Moreover, previous literature described
that the response to lifestyle intervention for cardiometabolic health
may be influenced by several factors such as sex and age, highlighting
the importance of tailored actions.113,114 Our current systematic
review and meta-analysis did not address these interesting aspects;
thus, upcoming literature may focus on the analysis of the differential
response to exercise therapy linked to age, sex, and the age–sex
interaction.
Additional potential limitation is that data were often retrieved
from secondary outcomes of the selected studies, introducing a
potential inaccuracy tied to the power calculation of each study.
Finally, most RCTs evaluated the effect of aerobic exercise; as a result,
pooled analyses based on exercise modality were not performed for
blood pressure and insulin resistance.
6 | CONCLUSIONS
In conclusion, this systematic review and meta-analysis showed a ben-
eficial effect of physical exercise training in improving cardiometabolic
health of adults with overweight or obesity. In these subjects, blood
pressure, insulin resistance, and intrahepatic fat all decreased signifi-
cantly after an exercise training program. Given the prevalence of
these cardiometabolic risk factors in people with overweight or
obesity, such improvements might bring substantial health benefits in
this population. Our results indicate that blood pressure and insulin
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resistance may decrease to a larger extent in subjects with hyperten-
sion and with type 2 diabetes, respectively, reinforcing the importance
of physical activity in people with overweight or obesity and
comorbidities. Aerobic training has many well-known benefits on
cardiometabolic health and was indeed the most frequent type of
exercise assessed in studies included in our review. We were able to
assess the effect of different types of exercise training (aerobic,
combined aerobic and resistance, and HIIT) on intrahepatic fat, and
we found that all types of exercise were effective in reducing
intrahepatic fat. Therefore, given the multiple benefits of exercise on
major aspects of cardiometabolic health, individualized exercise
prescription should be more broadly included in the management of
people with overweight or obesity.
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